2 China has 10,9741 new cases and 59,060 deaths annually, an increasing trend. 2 Recently, many articles have shown that effective surgery, technical radiotherapy, and the addition of bevacizumab to standard chemotherapy can significantly improve survival in cervical cancer patients. 3 , 4 Unfortunately, the prognosis for patients with advanced or recurrent cervical cancer remains poor, and the treatment options remain limited. 5 Hence, exploring effective prognostic and therapeutic targets for cervical cancer is urgent.
← all excerpts
Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration.
1
—
—